Background & Significance



Similar documents
The Chemical Coper Steven D. Passik, PhD

Michigan Guidelines for the Use of Controlled Substances for the Treatment of Pain

Opioid Treatment Guidelines. Denis G. Patterson, DO University of Nevada, Reno 7/15/2015

02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION

Painkiller addiction and pseudoaddiction in SCD (presentation 2 in a series of 3)

Opioid Agreement for Center for Pain Management S.C.

Medical marijuana for pain and anxiety: A primer for methadone physicians. Meldon Kahan MD CPSO Methadone Prescribers Conference November 6, 2015

What you should know about treating your pain with opioids. Important information on the safe use of opioid pain medicine.

Prescription Medication Abuse: Skills for Prevention and Intervention

Pain, Addiction & Methadone

Opioid Contracts: A Tool for Providing Relief and Preventing Abuse?

Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998

Aberrant Drug-taking Behaviors: What Do We Know?

Michigan Board of Nursing Guidelines for the Use of Controlled Substances for the Treatment of Pain

The Cost of Pain and Economic Burden of Prescription Misuse, Abuse and Diversion. Angela Huskey, PharmD, CPE

Opioid Treatment Agreement

Addiction Medicine for FP / GP. Dr. Francisco Ward, DABPMR/PM SetonPainRehab.com setonpr@gmail.com

Traumatic Stress. and Substance Use Problems

Fraud, Waste and Abuse

HAWAII BOARD OF MEDICAL EXAMINERS PAIN MANAGEMENT GUIDELINES

DEPRESSION Depression Assessment PHQ-9 Screening tool Depression treatment Treatment flow chart Medications Patient Resource

North Bay Regional Health Centre

Treating Addiction in Chronic Pain Patients A Clinical Journey. Brad Anderson, MD Chief, Department of Addiction Medicine Kaiser Permanente Northwest

KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE

New York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery

Table of Contents. I. Introduction II. Summary A. Total Drug Intoxication Deaths B. Opioid-Related Deaths... 9

The Changing Face of Opioid Addiction:

Guidelines for Use of Controlled Substances for the Treatment of Pain

03/20/12. Recognize the right of patients to appropriate assessment and management of pain

Treatment of Chronic Pain: Our Approach

ADVISORY OPINION THE USE OF CONTROLLED SUBSTANCES FOR THE TREATMENT OF CHRONIC PAIN

Sample Patient Agreement Forms

Treatment of Prescription Opioid Dependence

DSM 5 Opioid Related Disorders. Dr. Phil O Dwyer Oakland University Brookfield Clinics

UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths

Dependence and Addiction. Marek C. Chawarski, Ph.D. Yale University David Metzger, Ph.D. University of Pennsylvania

Indiana University Health

TREATMENT MODALITIES. May, 2013

EXPLORING NALOXONE UPTAKE AND USE PUBLIC MEETING July 01 02, 2015 Fred Wells Brason II

Palmer MacKie, MD MS Director, Integrative Pain Program, Eskenazi Department of Medicine, IUSOM

Arkansas Emergency Department Opioid Prescribing Guidelines

MANAGEMENT OF CHRONIC NON MALIGNANT PAIN

Experiences of Assessing Misuse, Abuse and Opioid Use Disorders in Patients with Pain on Opioid Therapy

ST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;03/13;06/14;07/15

Acute Pain Management in the Opioid Dependent Patient. Maripat Welz-Bosna MSN, CRNP-BC

Considerations when Using Controlled Substances to Treat Chronic Pain

PSYCHIATRIC MENTAL HEALTH NURSE PRACTITIONER CLINICAL PRIVILEGES

DEPRESSION CARE PROCESS STEP EXPECTATIONS RATIONALE

Dartmouth Medical School Curricular Content in Addiction Medicine for Medical Students (DCAMMS) Keyed to LCME Core Competency Domains ***Draft***

MEDICAL ASSISTANCE BULLETIN

What you need for Your to know Safety about longterm. opioid pain care. What you need to know about long-term opioid

THE OFFICE OF SUBSTANCE ABUSE SERVICES REQUIREMENTS FOR THE PROVISION OF RESIDENTIAL DETOXIFICATION SERVICES BY PROVIDERS FUNDED WITH DBHDS RESOURCES

Managing Chronic Pain in Adults with Substance Use Disorders

Naltrexone Shared Care Guideline for the treatment of alcohol dependence and opioid dependance

Michael Brennan, MA, LMHC Providence St. Peter Hospital Crisis Services

Robert Okwemba, BSPHS, Pharm.D Philadelphia College of Pharmacy

MSD Guidelines for the Use of Controlled Substances for the Treatment of Pain

Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling

Benzodiazepine Detoxification and Reduction of Long term Use

OTC Abuse. Dr. Eman Said Abd-Elkhalek Lecturer of Pharmacology & Toxicology Faculty of Pharmacy Mansoura University

The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office

Congressional Testimony. Laurence M. Westreich, M.D. President, American Academy of Addiction Psychiatry

OPIOID PAIN MEDICATION Agreement and Informed Consent

TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION

Judith Martin, MD Medical Director, Substance Abuse Services, San Francisco DPH

Drug Treatment Considerations In The Elderly

Florida Medicaid: Mental Health and Substance Abuse Services

Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians

SECTION VII: Behavioral Health Services

Behavioral Health Best Practice Documentation

Psychiatric Comorbidity in Methamphetamine-Dependent Patients

CONTROLLED SUBSTANCE CONTRACT

DEPARTMENT OF PSYCHIATRY Centre Street Boston, MA 02130

Amphetamines Addiction

These changes are prominent in individuals with severe disorders, but also occur at the mild or moderate level.

ADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines

PROTOCOL SYNOPSIS Evaluation of long-term opioid efficacy for chronic pain

Project Objective: Integration of mental health and substance abuse with primary care services to ensure coordination of care for both services.

Appendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain

Mental Health Needs Assessment Personality Disorder Prevalence and models of care

Naltrexone and Alcoholism Treatment Test

Metropolitan Detention Center (MDC) DWI Addiction Treatment Programs (ATP) Outcome Study for DWI Offenders

SOMERSET DUAL DIAGNOSIS PROTOCOL OCTOBER 2011

Medical Cannabis and Addictions. October 2015 Charlie Reznikoff

MEDICAL ASSISTANCE BULLETIN

Assessment and Diagnosis of DSM-5 Substance-Related Disorders

Board encourages physicians to treat patients pain responsibly

Transcription:

The Impact Of A Structured Opioid Renewal Clinic On Aberrant Drug Behavior Outcomes At A Northeastern VA Medical Center Salimah H. Meghani, PhD, MBE, CRNP Assistant Professor, University of Pennsylvania School of Nursing Nancy Wiedemer,CRNP Pain Management Coordinator, Philadelphia VA Medical Center Background & Significance Development of the Opioid Renewal Clinic: A primary care based program to provide structured monitoring of opioid therapy for chronic pain patients at risk for substance abuse Background & Significance Veterans Health Administration National Pain Management Initiative, 1998 Joint Commission Pain Management Standards, 2000 Evidence for Acute and Cancer Pain management is strong Evidence for Chronic Pain management is evolving 1

Background & Significance Chronic Pain Management * Focus on improvement in function * Chronic Disease Management Model * Opioids are considered standard of care Incorporating Consensus Guidelines into Primary Care Practice at PVAMC Chronic Narcotic Use Policy 1998 Chronic Opioid Use Policy 2000 Major Principles Assessment diagnosis Use of Opioid Treatment Agreement One Provider responsible for Rx Urine Drug Testing Documentation The Problem Guidelines and policies available but they take too much time! Reluctance of PCPs, who care for the majority, to prescribe opioids Concern about diversion, abuse, addiction and regulatory scrutiny, particularly in a high risk population Prescribing opioids without assessment and without monitoring treatment outcomes 2

The Problem The Oxycontin Media Blitz Visit from the Investigator General Pharmacy Budget crisis $ 237,830 6 month (in 2001) cost of Oxycontin The Need Cost-effective strategies to support PCPs management of these patients. Action plan: Focus group meetings with PCPs Review of Literature for guidelines and evidence-based strategies Results of review of the literature formed the foundation of our program 3

Definition of Terms Physical Dependence Tolerance Abuse Addiction Withdrawal syndrome in response to abrupt dose reduction Pharmacologic property, dose may need to be increased to maintain effect The intentional misuse of a medication for nonpresribed effects ( e.g. mood alteration) Chronic neurobiologic disorder characterized by loss of control, craving, compulsive use despite harm Consensus Document: The American Academy of Pain Medicine, The American Pain Society, The American Society of Addiction Medicine Spectrum of Drug Misuse Self medication: mood, sleep, memories Undertreated pain (pseudoaddiction) Sharing medications Recreation: euphoria, rush high Addictive use Diversion for profit Criminal business Support medication costs Savage 2001 Differential Diagnosis of aberrant drug-related behavior Addiction Under-treated pain (Pseudoaddiction) Other psychiatric disorders( e.g.. Borderline personality disorder) Mild encephalopathy Family disturbances Criminal intent Portenoy,2003;Passik & Kirsh,2004 4

The Opioid Renewal Clinic: A Primary Care, Managed Approach to Opioid Therapy for Chronic Pain A Nurse Practitioner and Clinical Pharmacist managed service at the Philadelphia VA Medical Center Start-up date: September 2001 Opioid Renewal Clinic: Services Assist with management of challenging patients requiring structured prescribing and monitoring of long-term opioid therapy Patients with aberrant drug related behaviors r/o substance misuse vs. pseudoaddiction vs. addiction Patients with h/o addiction, recent addiction, active addiction Opioid Renewal Clinic: Services Assist with opioid titration and rotation Assist with routine opioid renewals Patients who have stabilized Part-time providers 5

Opioid Renewal Clinic Goals Facilitate appropriate treatment for each patient - opioid therapy if indicated and/or - addiction treatment Improve PCP confidence in prescribing opioids Improve monitoring and documentation Provide cost-effective care by decreasing miss-utilization of resources Opioid Renewal Clinic Procedure Consult from PCP Eligibility Workup and pain dx Opioid Treatment Agreement Baseline urine drug test THE PCP CONTINUES TO BE RESPONSIBLE TO PRESCRIBE OPIOIDS Opioid Renewal Clinic: Example of Strategies Opioid Treatment Agreement Second Chance Agreement Frequent visits Prescribing opioids on a short term basis (i.e. weekly or bi-weekly) Periodic urine drug testing Pill counts Co-management with addiction services 6

Monitor and Document the 4 As Analgesia (pain relief ) ADL s (functional ability) Adverse Effects (constipation, nausea ) Aberrant behavior (drug seeking or seeking pain relief) (Passick & Weinreb, 2000) Results 784 referrals 1/2/02 12/6/06 Aberrant behavior 366 (47%) UDT + for illegal drugs or unprescribed drugs, negative for prescribed drugs, overusing prescribed opioids No Aberrant Behavior 418 (53 %) Opioid rotation or titration H/O of recent substance abuse Conflicts with providers Part-time clinicians- referred for assistance with monthly monitoring Results (n= 784) 366 (47%) Documented aberrant behavior Resolution of aberrant behavior Discharge from ORC n=101 (28 %) self-discharged n= 86 (23 %) ORC discharged Referred for addiction therapy Consistently negative UDT 148 (40.4%) 187 (51 %) 24 (6.6 %) 7 (1.9 %) weaned from opioids 7

Purpose What are the demographic and clinical predictors of the resolution of aberrant drug behavior in a group of patients referred to the Opioid Renewal Clinic by their primary care providers? Methods (cont.) Setting Philadelphia VA Medical Center. Data Extraction Data were extracted by the professional information management staff of the Center using Veterans Health Information System and Technology Architecture (VistA) database. Methods Design Retrospective chart review Sample Consecutive patients (N=196) referred to ORC by their PCPs between 1/17/02 to 8/27/04 for aberrant behaviors including positive urine drug testing (UDT) or a pattern of early refill requests. 8

Methods (cont.) Data Extraction (cont.) Demographic (age, race, gender, marital status and, employment status, combat history, and service connection) Pain & Addiction (site of pain, primary pain diagnosis, number of pain diagnosis, drug and alcohol addiction) Physical/Psychological Comorbidity (Charlson index-a standard measure of the burden of medical comorbidity, history of depression, anxiety, post-traumatic stress disorder) Cohort for retrospective review 401 referrals 1/02 8/04 205 (51%) No aberrant behaviors 196 (49%) Documented aberrant behavior Resolution of aberrant behavior Discharge from ORC n= 22 (11%) self-discharged n= 67 (34%) ORC discharged Referred for addiction therapy Consistently negative UDT weaned from opioids 86 (43.9%) 82 (41.8%) 21 (10.7%) 7 (3.6%) Methods (cont.) Data Analysis Aberrant drug behavior outcomes were evaluated at one year following patients enrollment in the ORC. Aberrant behavior categorized as binary variable (0= resolution and 1= non-resolution ). Logistic regression to identify independent predictors of aberrant behavior outcomes. 9

Results (N=196) Outcome N % Aberrant behavior resolved 86 43.9% Aberrant behavior not resolved (N=110) Discharged from ORC Accepted addiction treatment Weaned for consistently negative urine for prescribed opioids Total 82 21 7 196 41.8% 10.7% 3.6% 100% Results (cont.) After controlling for several covariates, Logistic Regression analysis found three variables important in predicting aberrant drug behavior outcomes. 1. History of Cocaine Addiction: Most powerful predictor Hx. of Cocaine addiction increased the odds of failure (not resolved) by 4 times (OR = 3.805, CI, 1.47 to 9.82, p =.006). 2. Number of Pain Diagnoses: Every additional pain diagnosis reduced the odds of failure by about 14% (OR = 0.861, CI, 0.76 to 0.98, p = 0.02). Results (cont.) 3. Married v. Single Veterans Married individuals were 58% less likely to fail the ORC program than single individuals (OR= 0.419, CI, 0.18 to 0.98, p=.045) 10

Conclusions About half the patients resolved aberrant behavior within a structured opioid renewal program Veterans with cocaine dependence had significantly higher risk for failing the program reveals a need for a tailored intervention for this subgroup of patients. Those with higher level of pain may have higher motivation to adhere to the program s structure. Conclusions Marriage may be a proxy for social support. Having close social relationships has consistently been shown to be an important personal resource and a significant determinant of individual differences in morbidity and adherence to medical treatment for chronic illnesses (Holt-Lunstad, 2008; Revenson, 1995; DiMatteo, 2004). The role of marriage and social support with adherence to an opioid treatment program in a high risk population may be explored in further studies. Limitations ORC is a clinical program- No standardized instruments to establish pain levels, clinical pain diagnosis, and psychometrically-derived variables, and other patient characteristics or functional status were available. The study included mostly male veterans from a single medical center; therefore our results may not be generalizable to other populations. 11

Future Directions Prospective studies of the impact of structured risk management program using standardized measures Cost-benefit analysis of such a program References Wiedemer NL, Harden PS, Arndt IO, Gallagher RM. The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse. Pain Med 2007;8(7):573-84. D'Hoore, W., Sicotte, C., & Tilquin, C. (1993). Risk adjustment in outcome assessment: The charlson comorbidity index. Methods Inf Med, 32(5), 382-387. DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol 2004;23(2):207-18. Holt-Lunstad J, Birmingham W, Jones BQ. Is there something unique about marriage? The relative impact of marital status, relationship quality, and network social support on ambulatory blood pressure and mental health. Ann Behav Med 2008;35(2):239-44. Revenson TA, Gibofsky A. Marriage, social support, and adjustment to rheumatic disease. Bull Rheum Dis 1995;44(3):5-8. 12